Why are vitamin B12 and folate levels evaluated in anemia workups, and how can they be distinguished biochemically?

Prepare for the Clinical Chemistry and Pathologic of Biochemistry Exam with comprehensive questions, detailed explanations, and effective study strategies. Ace your test with confidence!

Multiple Choice

Why are vitamin B12 and folate levels evaluated in anemia workups, and how can they be distinguished biochemically?

Understanding how B12 and folate interact in one‑carbon metabolism helps explain why certain metabolites rise in deficiency and how to tell them apart. B12 is required for two key reactions: the conversion of methylmalonyl‑CoA to succinyl‑CoA and the remethylation of homocysteine to methionine (which uses 5‑methyl‑THF as the methyl donor). When B12 is deficient, methylmalonyl‑CoA accumulates and becomes methylmalonic acid (MMA) rises. At the same time, the remethylation of homocysteine is impaired, so homocysteine also increases. Folate deficiency, on the other hand, impairs the supply of the methyl donor for homocysteine remethylation, so homocysteine rises, but MMA does not accumulate because that pathway depends on B12, not folate. Therefore, a pattern of elevated MMA plus elevated homocysteine strongly supports B12 deficiency. If MMA is normal but homocysteine is elevated, folate deficiency is more likely. To help confirm folate status, measuring red cell (RBC) folate versus serum folate provides additional context: low RBC folate indicates true folate deficiency (long‑term folate depletion), whereas B12 deficiency typically does not cause a low RBC folate.

Understanding how B12 and folate interact in one‑carbon metabolism helps explain why certain metabolites rise in deficiency and how to tell them apart. B12 is required for two key reactions: the conversion of methylmalonyl‑CoA to succinyl‑CoA and the remethylation of homocysteine to methionine (which uses 5‑methyl‑THF as the methyl donor). When B12 is deficient, methylmalonyl‑CoA accumulates and becomes methylmalonic acid (MMA) rises. At the same time, the remethylation of homocysteine is impaired, so homocysteine also increases. Folate deficiency, on the other hand, impairs the supply of the methyl donor for homocysteine remethylation, so homocysteine rises, but MMA does not accumulate because that pathway depends on B12, not folate.

Therefore, a pattern of elevated MMA plus elevated homocysteine strongly supports B12 deficiency. If MMA is normal but homocysteine is elevated, folate deficiency is more likely. To help confirm folate status, measuring red cell (RBC) folate versus serum folate provides additional context: low RBC folate indicates true folate deficiency (long‑term folate depletion), whereas B12 deficiency typically does not cause a low RBC folate.

More practice questions